PPARGC1A and diabetes mellitus: Furthermore, PGC‐1α reduces proteolysis and oxidative stress in muscles atrophying due to glucocorticoid treatment [71], sepsis [72], chronic kidney disease [73], diabetes [67], and obesity [74].